A 37-amino acid long-acting acylated amylin analog that activates amylin and calcitonin receptors to modulate appetite signaling in homeostatic and hedonic brain regions, studied in clinical trials for weight management
In addition to monoaminergic systems, research suggests that BPC-157 may interact with inhibitory neurotransmission
Over the past two decades, therapies based on incretin hormones, spearheaded by glucagon-like peptide 1 (GLP1) receptor agonists (GLP1RAs), have become the treatment of choice for obesity and T2DM, and clinical evidence now suggests that these agents have benefits for CVD
Athlete sidebar: if you are in a tested sport If you compete under WADA rules, BPC-157 is prohibited as an unapproved substance
PRP requires blood draw and processing, typically performed in medical settings at considerable cost